BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02613598-completion@plaintrial.com
DTSTAMP:20261028T201345Z
DTSTART;VALUE=DATE:20210607
SUMMARY:Dose Escalation Study to Determine the Maximum Tolerated Dose of th
 e Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or R
 efractory Lymphoma — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02613598
URL:https://plaintrial.com/trial/NCT02613598
END:VEVENT
END:VCALENDAR